← Back
Silo Pharma
SILO · listed on Nasdaq · worth $3.68 million
$1.23
−3.01% today
Six insider buys in the last year, $7.7K in all. None in the last two weeks.
Green dot = an insider bought◆ = company newsA number = that many on nearby days · click a mark to see who, or read the filing
Reverse split 1-for-15 in Jun 2026. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what SILO ever actually traded at. The drop is real, but those huge old numbers aren't.
The shares anyone can buy and sell, leaving out those held by insiders and big long-term owners.
1.6M shares
90% of all shares
Shares borrowed and sold by investors who expect the price to drop.
Company insiders
In the last year, one insider bought Silo Pharma stock and none sold.
How each buyer's earlier purchases went: the stock about six months later, beside the S&P 500 over the same days. Purchases planned in advance are left out. Past results, not a forecast.
Chief Executive Officer
Eric Weisblum
Bought $3K on Nov 18, 2025 — 7,500 shares at $0.4033, 3.7% of what they now own.
0 of 2 earlier purchases did better than the S&P 500
Big investors
People and funds that reported owning 5% or more of Silo Pharma, newest first.
All reports
Every insider trade and SEC report we hold for Silo Pharma.
Newest first
ReportedTradeInsiderOf their holdingShares @ priceValue
Dec 16, 2025BoughtEric WeisblumDec 16, 2025 · Traded Dec 15, 2025 · Chief Executive Officer+1.2%2,500 @ $0.4200$1.1K
Dec 16, 2025BoughtEric WeisblumDec 16, 2025 · Traded Dec 15, 2025 · Chief Executive Officer+1.2%2,500 @ $0.4100$1K
Nov 21, 2025BoughtEric WeisblumNov 21, 2025 · Traded Nov 20, 2025 · Chief Executive Officer+0.5%1,000 @ $0.3700$370.00
Nov 20, 2025BoughtEric WeisblumNov 20, 2025 · Traded Nov 19, 2025 · Chief Executive Officer+2.1%4,500 @ $0.4050$1.8K
2 more with Pro →